Robust neuroprotective effects of intranasally delivered iNOS siRNA encapsulated in gelatin nanoparticles in the postischemic brain

Il Doo Kim; Elizabeth Sawicki; Hye Kyung Lee; Eun Hwa Lee; Heon Joo Park; Pyung Lim Han; Kyekyoon Kevin Kim; Hyungsoo Choi; Ja Kyeong Lee

doi:10.1016/j.nano.2016.01.002

Robust neuroprotective effects of intranasally delivered iNOS siRNA encapsulated in gelatin nanoparticles in the postischemic brain

Il Doo Kim, Elizabeth Sawicki, Hye Kyung Lee, Eun Hwa Lee, Heon Joo Park, Pyung Lim Han, Kyekyoon Kevin Kim, Hyungsoo Choi, Ja Kyeong Lee

Divison of Brain & Cognitive Sciences

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Abstract

The therapeutic efficacy of intranasal iNOS siRNA delivery was investigated in the postischemic rat brain after encapsulating on in gelatin nanoparticles (GNPs; diameter 188.0 ± 60.9 nm) cross-linked with 0.0667% glutaraldehyde (GA). Intranasally delivered GNPs were found in extracellular and intracellular compartments of many brain regions, including the olfactory bulb, cerebral cortex, and striatum at 1 hour after infusion and continued to be detected for days. Infarct volumes were markedly suppressed (maximal reduction to 42.1 ± 2.6%) at 2 days after 60 minutes of middle cerebral artery occlusion (MCAO) when iNOS siRNA/GNPs were delivered at 6 hours post-MCAO. In addition, this protective effect was manifested by reductions in neurological and behavioral deficits that were sustained for 2 weeks. Therapeutic potency of iNOS siRNA/GNPs was significantly greater and sustained longer than that of bare siRNA and prolonged and efficient iNOS by iNOS siRNA/GNP is responsible for the robust neuroprotective effect.

Original language	English
Pages (from-to)	1219-1229
Number of pages	11
Journal	Nanomedicine: Nanotechnology, Biology, and Medicine
Volume	12
Issue number	5
DOIs	https://doi.org/10.1016/j.nano.2016.01.002
State	Published - 1 Jul 2016

Bibliographical note

Publisher Copyright:
© 2016 Elsevier Inc.

Keywords

Gelatin nanoparticles
INOS
Intranasal delivery
MCAO
SiRNA

Access to Document

10.1016/j.nano.2016.01.002

Cite this

@article{89d9d0344aec48aa8c17811885c2878e,

title = "Robust neuroprotective effects of intranasally delivered iNOS siRNA encapsulated in gelatin nanoparticles in the postischemic brain",

abstract = "The therapeutic efficacy of intranasal iNOS siRNA delivery was investigated in the postischemic rat brain after encapsulating on in gelatin nanoparticles (GNPs; diameter 188.0 ± 60.9 nm) cross-linked with 0.0667% glutaraldehyde (GA). Intranasally delivered GNPs were found in extracellular and intracellular compartments of many brain regions, including the olfactory bulb, cerebral cortex, and striatum at 1 hour after infusion and continued to be detected for days. Infarct volumes were markedly suppressed (maximal reduction to 42.1 ± 2.6%) at 2 days after 60 minutes of middle cerebral artery occlusion (MCAO) when iNOS siRNA/GNPs were delivered at 6 hours post-MCAO. In addition, this protective effect was manifested by reductions in neurological and behavioral deficits that were sustained for 2 weeks. Therapeutic potency of iNOS siRNA/GNPs was significantly greater and sustained longer than that of bare siRNA and prolonged and efficient iNOS by iNOS siRNA/GNP is responsible for the robust neuroprotective effect.",

keywords = "Gelatin nanoparticles, INOS, Intranasal delivery, MCAO, SiRNA",

author = "Kim, {Il Doo} and Elizabeth Sawicki and Lee, {Hye Kyung} and Lee, {Eun Hwa} and Park, {Heon Joo} and Han, {Pyung Lim} and Kim, {Kyekyoon Kevin} and Hyungsoo Choi and Lee, {Ja Kyeong}",

note = "Publisher Copyright: {\textcopyright} 2016 Elsevier Inc.",

year = "2016",

month = jul,

day = "1",

doi = "10.1016/j.nano.2016.01.002",

language = "English",

volume = "12",

pages = "1219--1229",

journal = "Nanomedicine: Nanotechnology, Biology, and Medicine",

issn = "1549-9634",

publisher = "Elsevier Inc.",

number = "5",

}

TY - JOUR

T1 - Robust neuroprotective effects of intranasally delivered iNOS siRNA encapsulated in gelatin nanoparticles in the postischemic brain

AU - Kim, Il Doo

AU - Sawicki, Elizabeth

AU - Lee, Hye Kyung

AU - Lee, Eun Hwa

AU - Park, Heon Joo

AU - Han, Pyung Lim

AU - Kim, Kyekyoon Kevin

AU - Choi, Hyungsoo

AU - Lee, Ja Kyeong

PY - 2016/7/1

Y1 - 2016/7/1

N2 - The therapeutic efficacy of intranasal iNOS siRNA delivery was investigated in the postischemic rat brain after encapsulating on in gelatin nanoparticles (GNPs; diameter 188.0 ± 60.9 nm) cross-linked with 0.0667% glutaraldehyde (GA). Intranasally delivered GNPs were found in extracellular and intracellular compartments of many brain regions, including the olfactory bulb, cerebral cortex, and striatum at 1 hour after infusion and continued to be detected for days. Infarct volumes were markedly suppressed (maximal reduction to 42.1 ± 2.6%) at 2 days after 60 minutes of middle cerebral artery occlusion (MCAO) when iNOS siRNA/GNPs were delivered at 6 hours post-MCAO. In addition, this protective effect was manifested by reductions in neurological and behavioral deficits that were sustained for 2 weeks. Therapeutic potency of iNOS siRNA/GNPs was significantly greater and sustained longer than that of bare siRNA and prolonged and efficient iNOS by iNOS siRNA/GNP is responsible for the robust neuroprotective effect.

AB - The therapeutic efficacy of intranasal iNOS siRNA delivery was investigated in the postischemic rat brain after encapsulating on in gelatin nanoparticles (GNPs; diameter 188.0 ± 60.9 nm) cross-linked with 0.0667% glutaraldehyde (GA). Intranasally delivered GNPs were found in extracellular and intracellular compartments of many brain regions, including the olfactory bulb, cerebral cortex, and striatum at 1 hour after infusion and continued to be detected for days. Infarct volumes were markedly suppressed (maximal reduction to 42.1 ± 2.6%) at 2 days after 60 minutes of middle cerebral artery occlusion (MCAO) when iNOS siRNA/GNPs were delivered at 6 hours post-MCAO. In addition, this protective effect was manifested by reductions in neurological and behavioral deficits that were sustained for 2 weeks. Therapeutic potency of iNOS siRNA/GNPs was significantly greater and sustained longer than that of bare siRNA and prolonged and efficient iNOS by iNOS siRNA/GNP is responsible for the robust neuroprotective effect.

KW - Gelatin nanoparticles

KW - INOS

KW - Intranasal delivery

KW - MCAO

KW - SiRNA

UR - http://www.scopus.com/inward/record.url?scp=84963655398&partnerID=8YFLogxK

U2 - 10.1016/j.nano.2016.01.002

DO - 10.1016/j.nano.2016.01.002

M3 - Article

C2 - 26945975

AN - SCOPUS:84963655398

SN - 1549-9634

VL - 12

SP - 1219

EP - 1229

JO - Nanomedicine: Nanotechnology, Biology, and Medicine

JF - Nanomedicine: Nanotechnology, Biology, and Medicine

IS - 5

ER -

Robust neuroprotective effects of intranasally delivered iNOS siRNA encapsulated in gelatin nanoparticles in the postischemic brain

Abstract

Bibliographical note

Keywords

Access to Document

Fingerprint

Cite this